NASDAQ:ABDC - Alcentra Capital Stock Price, News & Analysis

Alcentra Capital trades on the NASDAQ under the ticker symbol "ABDC."

Alcentra Capital announced a quarterly dividend on Monday, August 5th. Shareholders of record on Thursday, September 26th will be paid a dividend of $0.18 per share on Thursday, October 3rd. This represents a $0.72 dividend on an annualized basis and a yield of 8.09%. The ex-dividend date is Wednesday, September 25th. View Alcentra Capital's Dividend History.

Alcentra Capital announced that its board has authorized a stock repurchase plan on Friday, November 17th 2017, which permits the company to buyback $2,500,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback plans are generally a sign that the company's leadership believes its shares are undervalued.

Alcentra Capital Corp (NASDAQ:ABDC) issued its earnings results on Wednesday, August, 7th. The asset manager reported $0.20 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.20 by $0.00. The asset manager earned $6.14 million during the quarter, compared to analyst estimates of $6.11 million. Alcentra Capital had a return on equity of 8.30% and a net margin of 31.91%. View Alcentra Capital's Earnings History.

Alcentra Capital is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Alcentra Capital.

Press coverage about ABDC stock has been trending negative this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Alcentra Capital earned a news impact score of -2.3 on InfoTrie's scale. They also assigned headlines about the asset manager a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Alcentra Capital.

Alcentra Capital saw a drop in short interest in the month of July. As of July 31st, there was short interest totalling 15,900 shares, a drop of 32.6% from the June 30th total of 23,600 shares. Based on an average daily volume of 26,100 shares, the short-interest ratio is presently 0.6 days. Currently, 0.1% of the shares of the company are sold short. View Alcentra Capital's Current Options Chain.

Some companies that are related to Alcentra Capital include Diamond Hill Investment Group (DHIL), Fidus Investment (FDUS), Westwood Holdings Group (WHG), Value Line (VALU), Saratoga Investment (SAR), Monroe Capital (MRCC), Silvercrest Asset Management Group (SAMG), StoneCastle Financial (BANX), Great Elm Capital (GECC), Fifth Street Asset Management (FSAM), Hennessy Advisors (HNNA), U.S. Global Investors (GROW), Puhui Wealth Investment Managemnt (PHCF), Manning and Napier (MN) and Medley Management (MDLY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcentra Capital investors own include Energy Transfer LP Unit (ET), SunCoke Energy Partners (SXCP), THL Credit (TCRD), Cornerstone Total Return Fund (CRF), Garrison Capital (GARS), Arlington Asset Investment (AI), Capitala Finance (CPTA), CBL & Associates Properties (CBL), NGL Energy Partners (NGL) and SandRidge Permian Trust (PER).

Alcentra Capital's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (5.25%), Pacific Ridge Capital Partners LLC (3.55%), Morgan Stanley (3.41%), Oppenheimer & Co. Inc. (0.22%), Acadian Asset Management LLC (0.13%) and Appleton Partners Inc. MA (0.08%). Company insiders that own Alcentra Capital stock include Branko Krmpotic, David Scopelliti, Douglas J /Ma Greenlaw, Edward Grebow, Ellida Mcmillan, Paul J Echausse, Steven H Reiff, Suhail A Shaikh and T Ulrich Brechbuhl. View Institutional Ownership Trends for Alcentra Capital.

ABDC stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp and Oppenheimer & Co. Inc.. View Insider Buying and Selling for Alcentra Capital.

ABDC stock was bought by a variety of institutional investors in the last quarter, including Morgan Stanley, Pacific Ridge Capital Partners LLC, Appleton Partners Inc. MA and Acadian Asset Management LLC. Company insiders that have bought Alcentra Capital stock in the last two years include Branko Krmpotic, David Scopelliti, Douglas J /Ma Greenlaw, Edward Grebow, Ellida Mcmillan, Steven H Reiff, Suhail A Shaikh and T Ulrich Brechbuhl. View Insider Buying and Selling for Alcentra Capital.

Shares of ABDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ABDC stock can currently be purchased for approximately $8.90.

Alcentra Capital has a market capitalization of $114.63 million and generates $28.97 million in revenue each year. The asset manager earns $5.52 million in net income (profit) each year or $1.01 on an earnings per share basis. View Additional Information About Alcentra Capital.

The official website for Alcentra Capital is http://www.alcentracapital.com/.

Alcentra Capital's mailing address is 200 PARK AVENUE 7TH FLOOR, NEW YORK NY, 10166. The asset manager can be reached via phone at 212-922-8240 or via email at [email protected]